Cerus | CERS - Selling And Administration Expenses


Cerus reported $19.33M in Selling and Administration Expenses for its fiscal quarter ending in December of 2024.





Selling And Administration Expenses Change Date
Cerus USD 19.33M 1.55M Dec/2024
GRIFOLS EUR 289M 8M Jun/2026
Haemonetics USD 118.94M 1.99M Jun/2026
Neogen USD 99.8M 1.3M Mar/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Plus Therapeutics USD 4.26M 779K Mar/2026
Quidel USD 189.7M 9.6M Jun/2026
Rockwell Medical USD 4.04M 330K Jun/2024
STAAR Surgical USD 45.14M 6.5M Jun/2026
Terumo JPY 109.7B 5.11B Jun/2026
Utah Medical Products USD 2.56M 48K Mar/2026